Lung Adenocarcinoma

Lung adenocarcinoma is a type of non-small cell lung cancer and is the most frequent histological type of lung cancer, often triggered by aberrations in a driver oncogene. Here is the latest research.

May 31, 2020

The Association of BAP1 Loss-of-Function With the Defect in Homologous Recombination Repair and Sensitivity to PARP-Targeted Therapy

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Haitang YangRen-Wang Peng
May 31, 2020
Comment / Editorial

Transitional Mesothelioma and Artificial Intelligence: Do We Need One More Subtype? and Do We Need Computers to Identify Them?

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Michele Carbone
May 31, 2020

Feasibility and Safety of Neoadjuvant Alectinib in a Patient With ALK-Positive Locally Advanced NSCLC

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Chao ZhangWen-Zhao Zhong
May 31, 2020
Comment / Editorial

Lung Cancer in Peru

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Rossana RuizLuis Mas
June 2, 2020

Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells

Journal of Cellular and Molecular Medicine
Fushi HanShuzhen Chen
May 30, 2020

Harnessing natural killer immunity in metastatic small cell lung cancer

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Sarah A BestKate D Sutherland
May 27, 2020
Preprint

Mutations strengthened SARS-CoV-2 infectivity

arXiv Quantitative Biology
Jiahui ChenGuo-Wei Wei
May 31, 2020

Response to Letter to the Editor by Yang et al

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Raffit HassanYves Pommier
May 28, 2020
Open Access

Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma

Frontiers in Cell and Developmental Biology
Alvaro Gonzalez-RajalAndrew Burgess

Sign up to follow this feed and discover related papers.

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Adrenocortical Carcinoma

Adrenocortical carcinoma (acc) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

EGFR In Non-Small Cell Lung Carcinoma

Around 10-35% of non-small cell lung carcinomas have drug-sensitizing mutations in the epidermal growth factor receptor (EGFR) gene. In these cases, tyrosine kinase inhibitor therapy is recommended. Find the latest research on EGFR and non-small cell lung carcinoma here.

© 2020 Meta ULC. All rights reserved
/feed-previews/lung-adenocarcinoma/fc50d710-d582-4a0f-bb3c-88ce72e1ff35